Recent News

• 02.06.2026 - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 01.02.2026 - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 12.05.2025 - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 02.03.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.30.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.27.2026 - EX-99.1 EX-99.1
• 01.27.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 01.09.2026 - EX-99.1 EX-99.1
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities